Andreas Loos

Utility of the <scp>P</scp>19 suppressor of gene‐silencing protein for production of therapeutic antibodies in <i><scp>N</scp>icotiana</i> expression hosts

Freydoun Garabagi, Erin Gilbert, Andreas Loos et al. · Plant Biotechnology Journal · 2012 · 118 citations · Full text

Life Sciences, Biotechnology, Plant Sciences +15

Expression and glycoengineering of functionally active heteromultimeric IgM in plants

Andreas Loos, Clemens Grünwald‐Gruber, Friedrich Altmann et al. · Proceedings of the National Academy of Sciences · 2014 · 83 citations · Full text

Life Sciences, Biochemistry, Biotechnology +17

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

Michael S. Piepenbrink, Jun‐Gyu Park, Fatai S. Oladunni et al. · Cell Reports Medicine · 2021 · 73 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

The human anti‐HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down‐regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant‐based expression platforms

Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta et al. · Biotechnology Journal · 2014 · 69 citations · Full text

Life Sciences, Biochemistry, Plant Sciences +16

Structural and functional characterization of an anti‐West Nile virus monoclonal antibody and its single‐chain variant produced in glycoengineered plants

Huafang Lai, Junyun He, Jonathan Hurtado et al. · Plant Biotechnology Journal · 2014 · 64 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17